FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093706 [Registered on: 26/08/2025] Trial Registered Prospectively
Last Modified On: 25/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Crossover Trial 
Public Title of Study   Effect of dexamethasone with ropivacaine in a regional plane block to provide better pain relief in patients undergoing gall bladder surgery 
Scientific Title of Study   Comparative Evaluation of Dexamethasone as an adjuvant to 0.25 percent Ropivacaine vs 0.25 percent Ropivacaine with Normal Saline in External Oblique Intercostal Plane Block in patients undergoing Laparoscopic Cholecystectomy 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Keerthana R 
Designation  DNB Resident 
Affiliation  Ayushman Hospital and Health Services 
Address  Department of Anaesthesiology Operation Theatre Third floor Ayushman Hospital and Health Services Sector 10 Dwarka New Delhi

New Delhi
DELHI
110075
India 
Phone  9061366174  
Fax    
Email  keerthanar798@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mamta Dhir 
Designation  HOD and Senior Consultant, Anaesthesia 
Affiliation  Ayushman Hospital and Health Services 
Address  Department of Anaesthesiology Operation Theatre Third floor Ayushman Hospital and Health Services Sector 10 Dwarka New Delhi

New Delhi
DELHI
110075
India 
Phone  9899828043  
Fax    
Email  mamsdhir27@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kriti Singh 
Designation  Senior Consultant, Anaesthesia 
Affiliation  Ayushman Hospital and Health Services 
Address  Department of Anaesthesiology Operation Theatre Third floor Ayushman Hospital and Health Services Sector 10 Dwarka New Delhi

New Delhi
DELHI
110075
India 
Phone  9890144118  
Fax    
Email  drkritisingh@gmail.com  
 
Source of Monetary or Material Support  
Ayushman Hospital and Health Services Sector 10 Dwarka New Delhi 
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Keerthana R  Ayushman Hospital and Health Services  Department of Anaesthesiology Operation Theatre Third floor Ayushman Hospital and Health services Sector 10 Dwarka New Delhi
South West
DELHI 
9061366174

keerthanar798@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ayushman Hospital and Health Services Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K800||Calculus of gallbladder with acutecholecystitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  0.25% Ropivacaine 20cc with Dexamethasone 1ml(4mg) on each side  Given bilaterally in External Oblique Intercostal Plane Block as a part of multimodal analgesia in Laparoscopic Cholecystectomy patients. Study will be done over a period of one year 
Comparator Agent  0.25% Ropivacaine 20cc with Normal Saline (1ml) on each side  Given bilaterally in External Oblique Intercostal Plane Block as a part of multimodal analgesia in Laparoscopic Cholecystectomy patients. Study will be done over a period of one year 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  With ASA physical status classification of I and II
Scheduled to undergo elective laparoscopic cholecystectomy surgery
 
 
ExclusionCriteria 
Details  Patient refusal
Coagulation disorders
Liver or kidney disease
Abdominal surgery history
Infection in the block application area
Chronic opioid use
Local anaesthetic allergy
Pregnancy or BMI less than 18 or more than 35
Diabetes Mellitus
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
24 hour tramadol consumption in mg  15,30,60 mins
2,6,12,24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
Numerical Rating Scale  15,30,60 mins
2,6,12,24 hours 
Post Operative Nausea and Vomiting Score  15,30,60 mins
2,6,12,24 hours 
Sedation Score  15,30,60 mins
2,6,12,24 hours 
Blood glucose levels 6hrs after block  6 hrs 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   05/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Pain following laparoscopic cholecystectomy is a common complaint that prolongs hospital stay and therefore increases morbidity. Most patients experience mild to moderate pain after laparoscopic cholecystectomy. External oblique intercostal plane block is a novel block, which has been described as an important modification of the fascial plane blocks that can consistently involve the upper lateral abdominal walls. Ropivacaine is a long acting local anaesthetic and has a documented better safety profile than other local anaesthetics. . Dexamethasone is a highly potent, long-acting glucocorticoid with analgesic, antiemetic, and anti-inflammatory properties, and when used as an adjuvant in peripheral nerve blocks, increases the duration of analgesia with minimal side effects and has an added advantage in decreasing postoperative nausea and vomiting. The proposed study aims to assess the efficacy of dexamethasone as an adjuvant to ropivacaine in comparison to plain ropivacaine on External oblique intercostal plane block in patients undergoing laparoscopic cholecystectomy as a part of multimodal analgesia. We hypothesize that the addition of dexamethasone 8 mg to ropivacaine 0.25 percent in  External oblique intercostal plane block would prolong the analgesic effect and reduce 24hr tramadol consumption when compared with plain ropivacaine 0.25 percent  in patients undergoing laparoscopic cholecystectomy.  
Close